Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Cynamon

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Antimicrobial Agents and Chemotherapy|January 1, 1996
Activity of pyrazinamide in a murine model against Mycobacterium tuberculosis isolates with various levels of in vitro susceptibilityS P Klemens, C A Sharpe, M H Cynamon
The Journal of Antimicrobial Chemotherapy|December 23, 2003
BB-3497, a peptide deformylase inhibitor, is active against Mycobacterium tuberculosisMichael H Cynamon, Enriques Alvirez-Freites, Anthony E T Yeo
The American Journal of the Medical Sciences|January 1, 1983
Mycobacterium gordonae as a human hepato-peritoneal pathogen, with a review of the literatureP B Kurnik, U Padmanabh, C Bonatsos, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2002
In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosisEnrique J Alvirez-Freites, Janna L Carter, Michael H Cynamon
Antimicrobial Agents and Chemotherapy|May 1, 1999
Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine modelM H Cynamon, S P Klemens, C A Sharpe, et al.
Journal of Bacteriology|May 6, 2003
Attenuation of Mycobacterium tuberculosis by disruption of a mas-like gene or a chalcone synthase-like gene, which causes deficiency in dimycocerosyl phthiocerol synthesisTatiana D Sirakova, Vinod S Dubey, Michael H Cynamon, et al.
The Journal of Pediatrics|September 1, 1983
Management of chloramphenicol intoxication in infancy by charcoal hemoperfusionM Freundlich, H Cynamon, A Tamer, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1999
Evaluation of rifapentine in long-term treatment regimens for tuberculosis in miceA M Lenaerts, S E Chase, A J Chmielewski, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1999
High-dose isoniazid therapy for isoniazid-resistant murine Mycobacterium tuberculosis infectionM H Cynamon, Y Zhang, T Harpster, et al.
Journal of Bacteriology|July 18, 2003
Biochemical function of msl5 (pks8 plus pks17) in Mycobacterium tuberculosis H37Rv: biosynthesis of monomethyl branched unsaturated fatty acidsVinod S Dubey, Tatiana D Sirakova, Michael H Cynamon, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Antimicrobial Agents and Chemotherapy|January 1, 1996
Activity of pyrazinamide in a murine model against Mycobacterium tuberculosis isolates with various levels of in vitro susceptibilityS P Klemens, C A Sharpe, M H Cynamon
The Journal of Antimicrobial Chemotherapy|December 23, 2003
BB-3497, a peptide deformylase inhibitor, is active against Mycobacterium tuberculosisMichael H Cynamon, Enriques Alvirez-Freites, Anthony E T Yeo
The American Journal of the Medical Sciences|January 1, 1983
Mycobacterium gordonae as a human hepato-peritoneal pathogen, with a review of the literatureP B Kurnik, U Padmanabh, C Bonatsos, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2002
In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosisEnrique J Alvirez-Freites, Janna L Carter, Michael H Cynamon
Antimicrobial Agents and Chemotherapy|May 1, 1999
Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine modelM H Cynamon, S P Klemens, C A Sharpe, et al.
Journal of Bacteriology|May 6, 2003
Attenuation of Mycobacterium tuberculosis by disruption of a mas-like gene or a chalcone synthase-like gene, which causes deficiency in dimycocerosyl phthiocerol synthesisTatiana D Sirakova, Vinod S Dubey, Michael H Cynamon, et al.
The Journal of Pediatrics|September 1, 1983
Management of chloramphenicol intoxication in infancy by charcoal hemoperfusionM Freundlich, H Cynamon, A Tamer, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1999
Evaluation of rifapentine in long-term treatment regimens for tuberculosis in miceA M Lenaerts, S E Chase, A J Chmielewski, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1999
High-dose isoniazid therapy for isoniazid-resistant murine Mycobacterium tuberculosis infectionM H Cynamon, Y Zhang, T Harpster, et al.
Journal of Bacteriology|July 18, 2003
Biochemical function of msl5 (pks8 plus pks17) in Mycobacterium tuberculosis H37Rv: biosynthesis of monomethyl branched unsaturated fatty acidsVinod S Dubey, Tatiana D Sirakova, Michael H Cynamon, et al.
Pageof 10